Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

FDA 510(k) Submission Follows the Successful Completion of the Pivotal Human Clinical Trial

FDA 510(k) Clearance Anticipated During the Second Quarter of 2025